AARON REDMON: Open Payments
NPI 1568247088 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 4 payments from 4 companies in 2025. Trend: 2023 $88 · 2024 $172 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $122 |
| UCB, Inc. | 1 | $119 |
| Amgen Inc. | 1 | $110 |
| Haemonetics Corporation | 1 | $18 |
Products named: INGREZZA, Fintepla, UPLIZNA, TEG6S HEMOSTASIS SYSTEM.
Industry payments across TX — which companies pay providers there.
